Skip to main content
Top
Published in: Abdominal Radiology 2/2011

01-04-2011

High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications

Authors: Seung Eun Jung, Se Hyun Cho, Jin Hee Jang, Joon-Yeol Han

Published in: Abdominal Radiology | Issue 2/2011

Login to get access

Abstract

Purpose: To evaluate the complications of high-intensity focused ultrasound (HIFU) in patients with hepatic and pancreatic cancer. Materials and Methods: From January 2006 to December 2008, 133 sessions of HIFU treatment were performed in 114 consecutive patients with primary hepatic tumor (n = 57), hepatic metastasis (n = 22), and pancreatic cancer (n = 35) under general anesthesia. The extracorporeal, ultrasound-guided Model-JC system (HAIFU, Chongqing, China) was used. Artificial pleural effusion was created to obtain an adequate sonographic window for ablating hepatic dome masses in 53 patients. We reviewed medical records and imaging findings before, during, and after HIFU. Results: All patients had skin redness, edema, and pain in the treatment regions. All hepatic tumor patients had necrosis of the ribs along the main ultrasound beam path that did not require further treatment. Major complications included biliary obstruction, symptomatic pleural effusion, pneumothorax and fistula formation between an abdominal wall abscess and the ablated hepatic tumor. In 35 pancreatic cancer patients, major complications included third-degree burns and fistula formation between the tumor and duodenum. Delayed complications in hepatic tumor patients included a diaphragmatic rupture and rib fractures along the ultrasound pathway. Conclusion: The complications of HIFU develop mainly around the targeted lesions or along the ultrasound beam pathway. It is essential to have awareness of the possible complications related to HIFU and its imaging features for to avoiding serious complications.
Literature
1.
go back to reference Kennedy JE, Ter Haar GR, Cranston D (2003) High intensity focused ultrasound: surgery of the future? Br J Radiol 76:590–599PubMedCrossRef Kennedy JE, Ter Haar GR, Cranston D (2003) High intensity focused ultrasound: surgery of the future? Br J Radiol 76:590–599PubMedCrossRef
2.
go back to reference Li CX, Xu GL, Jiang ZY, et al. (2004) Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. World J Gastroenterol 10:2201–2204PubMed Li CX, Xu GL, Jiang ZY, et al. (2004) Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. World J Gastroenterol 10:2201–2204PubMed
3.
go back to reference Wu F, Wang ZB, Chen WZ, et al. (2004) Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem 11:149–154PubMedCrossRef Wu F, Wang ZB, Chen WZ, et al. (2004) Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem 11:149–154PubMedCrossRef
4.
go back to reference Illing RO, Kennedy JE, Wu F, et al. (2005) The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 93:890–895PubMedCrossRef Illing RO, Kennedy JE, Wu F, et al. (2005) The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 93:890–895PubMedCrossRef
5.
go back to reference Wu F, Wang ZB, Chen WZ, et al. (2005) Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 235:659–667PubMedCrossRef Wu F, Wang ZB, Chen WZ, et al. (2005) Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 235:659–667PubMedCrossRef
6.
go back to reference Li YY, Sha WH, Zhou YJ, Nie YQ (2007) Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol 22:2148–2154PubMedCrossRef Li YY, Sha WH, Zhou YJ, Nie YQ (2007) Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol 22:2148–2154PubMedCrossRef
7.
go back to reference Park MY, Jung SE, Cho SH, et al. (2009) Preliminary experience using high intensity focused ultrasound for treating liver metastasis from colon and stomach cancer. Int J Hyperthermia 25:180–188PubMedCrossRef Park MY, Jung SE, Cho SH, et al. (2009) Preliminary experience using high intensity focused ultrasound for treating liver metastasis from colon and stomach cancer. Int J Hyperthermia 25:180–188PubMedCrossRef
8.
go back to reference Wu F, Wang ZB, Zhu H, et al. (2005) Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology 236:1034–1040PubMedCrossRef Wu F, Wang ZB, Zhu H, et al. (2005) Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology 236:1034–1040PubMedCrossRef
9.
go back to reference Hwang JH, Wang YN, Warren C, et al. (2009) Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med Biol 35:967–975PubMedCrossRef Hwang JH, Wang YN, Warren C, et al. (2009) Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med Biol 35:967–975PubMedCrossRef
10.
go back to reference Haar GT, Coussios C (2007) High intensity focused ultrasound: physical principles and devices. Int J Hyperthermia 23:89–104PubMedCrossRef Haar GT, Coussios C (2007) High intensity focused ultrasound: physical principles and devices. Int J Hyperthermia 23:89–104PubMedCrossRef
11.
go back to reference Li JJ, Xu GL, Gu MF, et al. (2007) Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors. World J Gastroenterol 13:2747–2751PubMed Li JJ, Xu GL, Gu MF, et al. (2007) Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors. World J Gastroenterol 13:2747–2751PubMed
12.
go back to reference Goldberg SN, Grassi CJ, Cardella JF, et al. (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739PubMedCrossRef Goldberg SN, Grassi CJ, Cardella JF, et al. (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739PubMedCrossRef
14.
go back to reference Wu F, Chen WZ, Bai J, et al. (2001) Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 27:1099–1106PubMedCrossRef Wu F, Chen WZ, Bai J, et al. (2001) Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 27:1099–1106PubMedCrossRef
15.
go back to reference Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH (2008) High-intensity focused ultrasound: current potential and oncologic applications. Am J Roentgenol 190:191–199CrossRef Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH (2008) High-intensity focused ultrasound: current potential and oncologic applications. Am J Roentgenol 190:191–199CrossRef
16.
go back to reference Coussios CC, Farny CH, Haar GT, Roy RA (2007) Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU). Int J Hyperthermia 23:105–120PubMedCrossRef Coussios CC, Farny CH, Haar GT, Roy RA (2007) Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU). Int J Hyperthermia 23:105–120PubMedCrossRef
17.
go back to reference Daum DR, Smith NB, King R, Hynynen K (1999) In vivo demonstration of noninvasive thermal surgery of the liver and kidney using an ultrasonic phased array. Ultrasound Med Biol 25:1087–1098PubMedCrossRef Daum DR, Smith NB, King R, Hynynen K (1999) In vivo demonstration of noninvasive thermal surgery of the liver and kidney using an ultrasonic phased array. Ultrasound Med Biol 25:1087–1098PubMedCrossRef
18.
go back to reference Wu F, Wang ZB, Chen WZ, et al. (2004) Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Ann Surg Oncol 11:1061–1069PubMedCrossRef Wu F, Wang ZB, Chen WZ, et al. (2004) Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Ann Surg Oncol 11:1061–1069PubMedCrossRef
19.
go back to reference Cochard E, Prada C, Aubry JF, Fink M (2009) Ultrasonic focusing through the ribs using the DORT method. Med Phys 36:3495–3503PubMedCrossRef Cochard E, Prada C, Aubry JF, Fink M (2009) Ultrasonic focusing through the ribs using the DORT method. Med Phys 36:3495–3503PubMedCrossRef
Metadata
Title
High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications
Authors
Seung Eun Jung
Se Hyun Cho
Jin Hee Jang
Joon-Yeol Han
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 2/2011
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-010-9628-2

Other articles of this Issue 2/2011

Abdominal Radiology 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.